Funding

Since 2020, we have been receiving funding and support from:

Public funding:

• Biotechnology Center TU Dresden
• National Center for Tumor Diseases Dresden (NCT)
• Deutsche Forschungsgemeinschaft
• Bundesministerium für Bildung und Forschung
  SNV-CHEM - 01KD25027

• German Translational Cancer Consortium 
• German Academic Exchange Service
• CASUS
• EPPerMed
• EU Marie Skłodowska-Curie Actions

Foundations:

• Mildred Scheel Early Career Center of the TU Dresden (MSNZ)
  The MSNZ is funded by the German Cancer Aid
• Kosing foundation
• Gilbert Family Foundation

Industry: 

• Ardeypharm GmbH